Scroll To Top
Search by Speciality

14th European Meeting on HIV & Hepatitis -Treatment strategies & Antiviral Drug Resistance

Roma Eventi Fontana di Trevi * | Rome , ITALY
From 630 to 1230 EUR
Event Preview
EXPIRED
This event
is Finished
Title: 14th European Meeting on HIV & Hepatitis -Treatment strategies & Antiviral Drug Resistance
Specialty: Immunology
Dates: From May, 25, 2016 to May, 27, 2016
Location: Rome , ITALY
Type: Meeting
Registration Cost: From 630 to 1230 EUR
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
May
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for ROME , Italy.
General Info
Event Venue:

Roma Eventi Fontana di Trevi *

ROME , ITALY Visit the Venue to read more
Currency:
EUR
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

We are proud to announce the 14th edition of the  European Meeting o HIV & Hepatitis - Treatment strategies & Antiviral Drug Resistance, preliminarily scheduled to take place on 25 - 27 May  2016 in Rome, Italy.


This meeting was started 15 years ago with the objective to provide clinical virologists and other infectious diseases treating specialists involved in both research and clinical practice with the opportunity to share data and discuss their clinical application. The focus of the workshop at the time was specifically on HIV antiretroviral drug resistance, which was the main challenge facing the clinician a decade ago. Hence the original name as the European Drug Resistance workshop.


Over the years the challenges facing European clinicians treating HIV patients expanded. As resistance was better understood and managed, broader treatment issues (adherence, toxicity, etc.) were added to the workshop. Similarly, as better treatments for HCV became available, many of them were required to treat viral Hepatitis as well. Therefore the workshop (and its name) were expended to keep pace with the needs of the European clinicians – The European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance. Although resistance is still an important feature of the meeting, the other key topics in treatment strategies are addressed – similarly although HIV remains very much a key component – treatment of Hepatitis infection is also included.


In the last decade the meeting has been able to capture a constant group of leading clinicians and researchers from Europe.  The European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance is a unique European platform for clinicians and clinical virologists to discuss the latest developments in antiviral therapy for HIV, HCV and HBV and for translating them into new treatment strategies to further improve clinical care.


By attending this meeting, you will receive a full overview of the latest developments in Hepatitis B, C and HIV, translated to clinical practice. The meeting will provide ample time for Q & A, discussion and interaction in a balanced and neutral scientific environment. Furthermore, much attention will be given to clinical management through extensive clinical case discussions.


We look forward to seeing you in Rome!

Registration Needs updating Register Now
Currency:

EUR

Registration Cost
Type
Early Registration

2015-12-25
Late Registration From: 2015-12-26 To: 0--
On site Registration
Academia
630
730
930
Sponsoring industry
730
830
1030
Industry
930
1030
1230

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Accommodation:

Fontana di Trevi Conference Center    

35, Piazza della Pilotta Rome Italy

Scientific Content Up to Date
Submission Info

Abstracts should contain the following four components:


Background: a concise statement of the issue under investigation or a hypothesis;

Materials & Methods: the experimental methods used (including the statistical analyses employed);

Results: specific findings (promises such as “to be completed” or “to be presented” are not acceptable);

Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as “the results will be discussed” are not acceptable).

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included. The maximum word count for the abstract body is 500 words.


Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.


ABSTRACT SUBMISSION


Authors can submit their abstracts electronically using the button on the right “Abstract Submission”. You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.


CATEGORIES FOR ABSTRACT SUBMISSION


For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.


TOPICS FOR ABSTRACT SUBMISSION


Selection of the most appropriate topic is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. Abstracts will be accepted either for oral or poster presentation.


Abstracts can be submitted under the following categories:


Mechanism of Antiviral Drug Resistance (Hepatitis B, Hepatitis C and HIV)

Resistance to Antiviral Drugs (Hepatitis B, Hepatitis C and HIV)

Spread of Drug Resistance

Clinical Implications of Antiviral Drug Resistance (Hepatitis B, Hepatitis C and HIV)

Novel Diagnostic Technologies & Approaches

Treatment Strategies for HIV/ Hepatitis infected Patients

Therapeutic Challenges in Resource-limited settings

Viral Evolution & Genetic Diversity

Clinical case

Sponsors Exhibitors
General Info

Virology Education B.V.

Biltstraat 106

3572 BJ Utrecht

The Netherlands

P: +31 (0)30 230 7140

 F: +31 (0)30 230 7148

E: Info@virology-education.com

Chamber of Commerce Utrecht, nr 30171841 – VAT number  NL809658380B01

Contact
Organising Agency

Virology Education B.V.

Biltstraat 106

3572 BJ Utrecht

The Netherlands

P: +31 (0)30 230 7140

 F: +31 (0)30 230 7148

E: Info@virology-education.com

Chamber of Commerce Utrecht, nr 30171841 – VAT number  NL809658380B01

Event map
Revelant Events